{"id":394531,"date":"2026-04-23T23:53:11","date_gmt":"2026-04-23T23:53:11","guid":{"rendered":"https:\/\/www.newsbeep.com\/nz\/394531\/"},"modified":"2026-04-23T23:53:11","modified_gmt":"2026-04-23T23:53:11","slug":"regeneron-inks-drug-pricing-deal-with-trump-will-offer-hearing-loss-therapy-for-free","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/nz\/394531\/","title":{"rendered":"Regeneron inks drug pricing deal with Trump, will offer hearing-loss therapy for free"},"content":{"rendered":"<p>U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026 in Washington, DC. <\/p>\n<p>Alex Wong | Getty Images<\/p>\n<p><a href=\"https:\/\/www.cnbc.com\/quotes\/REGN\/\" rel=\"nofollow noopener\" target=\"_blank\">Regeneron<\/a> agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump, the White House said on Thursday.<\/p>\n<p>The biotech company will also offer the first hearing-loss gene therapy for free to eligible U.S. patients following regulatory approval of the product earlier Thursday.\u00a0<\/p>\n<p>Regeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under agreements with Trump. Those deals are part of his &#8220;most favored nation&#8221; effort to tie U.S. drug prices to the lowest ones in other developed nations.\u00a0<\/p>\n<p>The agreements also exempt the companies from tariffs for three years, including Trump&#8217;s <a href=\"https:\/\/www.cnbc.com\/2026\/04\/02\/trump-pharmaceutical-tariffs-100percent.html\" rel=\"nofollow noopener\" target=\"_blank\">planned up to 100% levies<\/a> on some pharmaceutical products.\u00a0The Trump administration has so far inked 17 deals, but is negotiating more with other biotech and pharma companies, said\u00a0CMS deputy administrator Chris Klomp during a White House event on Thursday. <\/p>\n<p>Regeneron&#8217;s deal comes just hours after the Food and Drug Administration <a href=\"https:\/\/investor.regeneron.com\/news-releases\/news-release-details\/otarmenitm-lunsotogene-parvec-cwha-approved-fda-first-and-only\" target=\"_blank\" rel=\"nofollow noopener\">approved <\/a>the company&#8217;s gene therapy, Otarmeni, which restored hearing in a small number of deaf children.\u00a0The treatment received an expedited approval under the FDA&#8217;s so-called\u00a0National Priority Voucher\u00a0program.<\/p>\n<p>The drug targets an ultra-rare genetic condition caused by a mutation that prevents the body from making a protein required for hearing. It&#8217;s a significant breakthrough for a subset of patients who have long depended on cochlear implants.<\/p>\n<p>In a March note, Piper Sandler analysts estimated that the gene therapy will rake in peak sales of $130 million.\u00a0<\/p>\n<p>&#8212; CNBC&#8217;s Angelica Peebles contributed to this report. <\/p>\n<p><a href=\"https:\/\/www.google.com\/preferences\/source?q=https:\/\/www.cnbc.com\/\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office&hellip;\n","protected":false},"author":2,"featured_media":394532,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[552,1673,38521,138,553,65,134,551,527,111,139,69,1674,124234,1430],"class_list":["post-394531","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-biotech-and-pharmaceuticals","tag-biotechnology","tag-breaking-news-business","tag-business","tag-business-news","tag-donald-trump","tag-health","tag-health-care-industry","tag-healthcare","tag-new-zealand","tag-newzealand","tag-nz","tag-pharmaceuticals","tag-regeneron-pharmaceuticals-inc","tag-united-states"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/394531","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=394531"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/394531\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/394532"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=394531"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=394531"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=394531"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}